University of Patras
Ανίχνευση μεταλλάξεων στο γονίδιο FGFR 1, στο γονίδιο GPR54, και στο γονίδιο της prokineticin 2 και του υποδεχέα της prokineticin receptor 2 σε ασθενείς με ανεπάρκεια GnRH (ιδιοπαθή υπογοναδοτροφικό υπογοναδισμό και σύνδρομο kallmann) και διερεύνηση της παρουσίας μεταλλαγών στο γονίδιο KaL1 σε ασθενείς με αγενεσία/δυσγενεσία νεφρού
Abstract
dc:descriptionBackground: Isolated GnRH deficiency (IGD) is characterized by afunctional deficit of GnRH production or secretion in the hypothalamusresulting in the loss of pulsatile secretion of GnRH and in impairedgonadotropin release, in the setting of otherwise normal anterior pituitaryanatomy and function and in the absence of secondary causes ofhypogonadotropic hypogonadism (HH). Kallmann syndrome (KS) ischaracterized by the association of IGD and anosmia, whereas patients withnormal olfactory function are referred as having normosmic IdiopathicHypogonadotropic Hypogonadism (nIHH).Objective: The objective of the study was to describe the different patientsphenotypes with IGD (KS and nIHH), to identify mutations in the KAL1,FGFR1, PROK2, PROKR2 and GPR54 genes and to correlate specificphenotypes with the patients genotypes. We also studied the presence ofKAL1 mutations in young children with unilateral renal agenesis/dysgenesis,in order to determine the incidence of KAL1 gene mutations in this population.In addition, we attempted to define the in vitro functionality of two FGFR1mutants (R254W and R254Q), resulting from two different amino acidsubstitutions of the same residue, and to correlate the in vitro findings to thepatients phenotypes.Patients: A total of 66 patients with IGD (26 with KS and 40 with nIHH) wereincluded in this study and mutation analysis of KAL1, FGFR1, PROK2,PROKR2 and GPR54 genes was performed for this group of patients. Wealso studied 13 children (up to the age of 15) with unilateral renal agenesis/dysgenesis, confirmed by imaging studies. Mutation analysis ofKAL1 gene was performed for the later group of patients.Methods: Gene mutation analysis methodology included DNA extraction,polymerase chain reaction amplification, and DNA sequence analysis of allexons of the KAL1, FGFR1, PROK2, PROKR2 and GPR54 genes. The invitrofunctional studies of two FGFR1 mutants (R254W and R254Q) includedevaluation of the mutant signaling activity and the expression levels, whichwere compared to the wild type (WT) receptor signaling activity andexpression. Signaling activity was determined by a FGF2/FGFR1dependenttranscription reporter assay. Receptor total expression levels were assessedby Western blot assay and receptor cell surface expression was measured byradiolabelled antibody binding assay.Results: We identified 5 different mutations in KAL1 gene in three unrelatedmale patients with KS (Δ514Κ, Α660Σ, Δ37Κ, T235S, deletion of exons 5-10of KAL1 gene with STS gene deletion) and one point mutation in FGFR1gene (R254W) in a male patient with nIHH.The in-vitro functional studies of the two FGFR1 mutants (R254W andR254Q) showed that R254W maximal receptor signaling capacity wasreduced by 45% (p<0.01), while maximal signaling of R254Q was alsoreduced (−15%) but the reduction was not statistically significant relative toWT. However, both mutants displayed diminished total protein expressionlevels (40% and 30% reduction relative to WT, respectively), while proteinmaturation was unaffected. Accordingly, cell surface expression levels of themutant receptors were also significantly reduced (35% p<0.01 and 15%p<0.05, respectively). Sequence analysis of KAL1 gene in the group of patients with unilateral renalagenesis/dysgenesis revealed genetic defects in KAL1 gene in a 12 year oldchild with associated anosmia, bimanual synkinesis of upper limbs andcryptorchidism. The genetic diagnosis of Kallmann syndrome was establishedin this case, enabling a prompt therapeutic intervention for puberty inductionat a later stage.Conclusions: Up to date very few mutations have been described in patientswith IGD in the Greek population and the genetic causes of IGD still remainsunclear in the majority of cases, pointing out the importance of further studiesfor determining the molecular pathogenesis of the disease. The phenotype ofrenal agenesis/dysgenesis strongly indicates the existence of KAL1 genedefects in the genotype of patients with sporadic KS, providing evidence forthe X-linked mode of inheritance and offering the opportunity for geneticcounseling. The detection of KAL1 gene mutations in children with unilateralrenal agenesis (URA) not only confirms the involvement of anosmin-1 (theproduct of KAL1 gene) in kidney organogenesis, but it can also lead to anearly prepubertal diagnosis of KS. Sequence analysis of KAL1 gene inpatients with URA is recommended in those cases with associated clinicalsigns of KS (e.g. anosmia, mirror movements, cryptorchidism, microphallus)or with familial history of hypogonadism or/and anosmia. The comparativefunctional analysis of two FGFR1 mutations affecting the same residue(R254W, R254Q) in two unrelated patients with IGD showed that both areloss-of-function mutations and that a tryptophan substitution at R254(R254W) is more disruptive to receptor structure than the more conservedglutamine substitution (R254Q). However, no clear correlation between the severity of in vitro loss-of-function and phenotypic presentation could beassigned.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Varnavas, Petros
- Βαρνάβας, Πέτρος
Subjects
dc:subject × 23- Σύνδρομο Kallmann
- Ιδιοπαθής υπογοναδοτροφικός υπογοναδισμός
- Ανεπάρκεια GnRH
- Ανοσμία
- Αγενεσία νεφρού
- Kallmann syndrome
- KS
- Idiopathic hypersomnolence hypogonadism
- GnRH deficiency
- IGO
- Anosmia
- Nenal agenesis
- KAL1
- FGFR1
- PROK2
- PROKR2
- GPR54 receptor
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41648